^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Ambezhu (bevacizumab biosimilar)
i
Other names: SCT510, SCT 510
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sinocelltech
Drug class:
VEGF-A inhibitor
Related drugs:
3ms
SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma (clinicaltrials.gov)
P2/3, N=405, Active, not recruiting, Sinocelltech Ltd. | Recruiting --> Active, not recruiting
Enrollment closed
|
sorafenib • Ambezhu (bevacizumab biosimilar) • finotonlimab (SCT-I10A)
Share via
